Key Dates

Related Announcements

RFA-DA-21-009 - Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice is to inform potential applicants to RFA-DA-21-009 of a pre-application webinar to provide submission information for the FOA “Interventions to Prevent Electronic Nicotine Delivery Systems Use Among Adolescents” that includes the following participating components of NIH: National Institute on Drug Abuse (NIDA), National Cancer Institute (NCI), Office of Behavioral and Social Sciences Research (OBSSR), and Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP). The intent of the webinar is to provide an overview of the initiative and to address questions pertinent to preparing applications. The webinar is optional and is not required for application submission.

Webinar Information:
Date: Monday, August 17, 2020
Time: 1:00 pm ET

Persons wishing to receive information for this webinar should contact the NIDA Program Contact, Belinda E. Sims at [email protected].

Prospective applicants are encouraged to submit their questions regarding the RFA to the Program Contact, Belinda E. Sims at [email protected] before August 17, 2020.

For emails to the Program Contact:

Please indicate “RFA on Prevention of ENDS Use Among Adolescents” in the subject line of your email

The email message should contain:

Name,
Institution,
Email address,
Request for information to access the webinar and/or state your question that is pertinent to preparing an application.

Prospective applicants with inquiries concerning the FOA, please contact the Scientific/Research contact listed in RFA-DA-21-009.

Inquiries

Please direct all inquiries to:

Belinda E. Sims, PhD
National Institute on Drug Abuse(NIDA)
Telephone: 301-402-1533
Email: [email protected]